Research location
Shinjuku
Tokyo, Japan
Advertisement
Research activity in Shinjuku
Tokyo, JapanCureCurrent currently publishes aggregate city-level research activity for this location: 48 trials and 58 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Shinjuku
48 linked trials · page 1 of 1A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)NCT07190248 · 2025-10-08 · 2 site observations
RECRUITING
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)NCT07033494 · 2025-07-16 · 1 site observation
RECRUITING
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)NCT06952504 · 2025-05-22 · 1 site observation
RECRUITING
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)NCT06925737 · 2025-05-13 · 1 site observation
RECRUITING
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)NCT06841354 · 2025-03-16 · 2 site observations
RECRUITING
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)NCT06623422 · 2024-10-21 · 1 site observation
RECRUITING
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)NCT06393374 · 2024-06-24 · 2 site observations
RECRUITING
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]NCT06422143 · 2024-06-10 · 1 site observation
RECRUITING
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)NCT06345729 · 2024-05-24 · 2 site observations
RECRUITING
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)NCT06312176 · 2024-04-14 · 2 site observations
RECRUITING
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)NCT06312137 · 2024-04-03 · 1 site observation
RECRUITING
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)NCT06170788 · 2023-12-15 · 2 site observations
RECRUITING
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart FailureNCT05392764 · 2022-09-10 · 1 site observation
RECRUITING
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic DiseaseNCT06760637 · 2025-01-06 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's DiseaseNCT06602258 · 2024-09-30 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's SyndromeNCT05946941 · 2023-09-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast CancerNCT05654623 · 2023-03-03 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First TimeNCT05362058 · 2022-06-03 · 1 site observation
COMPLETED
Real World Evidence of Long-term Safety and Efficacy in Patients Treated With Durvalumab After Concurrent Chemoradiation for Unresectable Stage III NSCLCNCT03995875 · 2019-07-25 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 DiabetesNCT03861052 · 2019-05-07 · 1 site observation
COMPLETED
Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes MellitusNCT03231709 · 2017-08-18 · 1 site observation
COMPLETED
The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using ActigraphyNCT02669082 · 2017-05-09 · 2 site observations
COMPLETED
Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease DementiaNCT03001557 · 2016-12-20 · 1 site observation
COMPLETED
A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to BiologicsNCT02960490 · 2016-11-26 · 2 site observations
COMPLETED
A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to MethotrexateNCT02960438 · 2016-10-20 · 2 site observations
COMPLETED
DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in JapanNCT02226822 · 2014-09-20 · 1 site observation
COMPLETED
A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDsNCT02308163 · 2014-08-08 · 1 site observation
COMPLETED
MADIT ASIA Cardiac Resynchronization TrialNCT01872234 · 2014-02-01 · 1 site observation
TERMINATED
Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid ArthritisNCT01850966 · 2012-09-12 · 1 site observation
COMPLETED
Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid ArthritisNCT01569074 · 2012-04-01 · 1 site observation
TERMINATED
Post-marketing Surveillance for the Clinical Safety and Effectiveness of Eribulin Mesylate in Patients With Inoperable or Recurrent Breast Cancer (Study HAL01S)NCT01463891 · 2011-07-19 · 1 site observation
COMPLETED
HIV Liver Regeneration Project for HIV Patients With Cirrhosis by Autologous Bone Marrow TransplantationNCT01309594 · 2011-03-01 · 1 site observation
UNKNOWN
Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes MellitusNCT01294436 · 2011-02-01 · 1 site observation
COMPLETED
High Dose BAYA1040_Nifedipine: a Long Term Combination StudyNCT01294215 · 2011-02-01 · 1 site observation
COMPLETED
Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus DarunavirNCT01294761 · 2011-02-01 · 1 site observation
COMPLETED
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's DiseaseNCT01251718 · 2010-12-01 · 1 site observation
COMPLETED
Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-NCT01129596 · 2010-06-10 · 1 site observation
COMPLETED
Safety Study of Maraviroc's Effect on Human OsteoclastsNCT01428986 · 2009-11-01 · 1 site observation
COMPLETED
Effect of Palivizumab on Later Recurrent Wheezing in Preterm InfantsNCT01072552 · 2008-03-01 · 1 site observation
COMPLETED
Comparison of Epzicom and Truvada for the Initial Once Daily HIV TreatmentNCT00544128 · 2007-10-01 · 1 site observation
COMPLETED
A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).NCT00383019 · 2006-11-14 · 1 site observation
COMPLETED
Nutrition and Exercise Intervention StudyNCT00926744 · 2006-04-01 · 1 site observation
UNKNOWN
First Line IRESSA™ Versus Carboplatin/Paclitaxel in AsiaNCT00322452 · 2006-03-01 · 1 site observation
COMPLETED
Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV TreatmentNCT00280969 · 2005-09-01 · 1 site observation
COMPLETED
Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.NCT00225524 · 2004-09-01 · 1 site observation
COMPLETED
Study Evaluating Effexor XR for Major Depression.NCT00225511 · 2004-06-01 · 1 site observation
COMPLETED
Iressa Case Control Study in JapanNCT00252759 · 2003-11-01 · 1 site observation
COMPLETED
Iressa 2nd Line Phase III Study in JapanNCT00252707 · 2003-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.